Ameriprise
BSTZ icon

Ameriprise’s BlackRock Science and Technology Term Trust BSTZ Stock Holding History

Ameriprise’s Portfolio BSTZ Stock Details BSTZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Buy
37,720
+9,552
+34% +$264K ﹤0.01% 3349
2026
Q1 		$624K Sell
28,168
-3,260
-10% -$73.1K ﹤0.01% 3498
2025
Q4 		$711K Buy
31,428
+8,351
+36% +$186K ﹤0.01% 3490
2025
Q3 		$511K Sell
23,077
-2,308
-9% -$49.6K ﹤0.01% 3615
2025
Q2 		$527K Buy
25,385
+12,308
+94% +$229K ﹤0.01% 3513
2025
Q1 		$232K Buy
13,077
+633
+5% +$12.9K ﹤0.01% 3747
2024
Q4 		$258K Buy
12,444
+528
+4% +$10.9K ﹤0.01% 3777
2024
Q3 		$229K Sell
11,916
-3,898
-25% -$74.4K ﹤0.01% 3717
2024
Q2 		$315K Sell
15,814
-5,028
-24% -$94.3K ﹤0.01% 3576
2024
Q1 		$404K Sell
20,842
-37,689
-64% -$677K ﹤0.01% 3492
2023
Q4 		$978K Sell
58,531
-1,100
-2% -$17.8K ﹤0.01% 3197
2023
Q3 		$984K Buy
59,631
+26,715
+81% +$472K ﹤0.01% 3153
2023
Q2 		$596K Buy
32,916
+65
+0.2% +$1.12K ﹤0.01% 3371
2023
Q1 		$614K Sell
32,851
-89,090
-73% -$1.56M ﹤0.01% 3346
2022
Q4 		$1.91M Buy
121,941
+77,045
+172% +$1.31M ﹤0.01% 2833
2022
Q3 		$792K Buy
44,896
+11,086
+33% +$228K ﹤0.01% 3221
2022
Q2 		$663K Sell
33,810
-12,028
-26% -$282K ﹤0.01% 3289
2022
Q1 		$1.35M Sell
45,838
-8,866
-16% -$264K ﹤0.01% 3076
2021
Q4 		$2.13M Sell
54,704
-7,282
-12% -$291K ﹤0.01% 2924
2021
Q3 		$2.39M Buy
61,986
+4,964
+9% +$201K ﹤0.01% 2804
2021
Q2 		$2.38M Sell
57,022
-77,567
-58% -$2.94M ﹤0.01% 2856
2021
Q1 		$4.79M Buy
134,589
+9,983
+8% +$364K ﹤0.01% 2417
2020
Q4 		$4.53M Sell
124,606
-46,358
-27% -$1.43M ﹤0.01% 2341
2020
Q3 		$4.39M Buy
170,964
+25,165
+17% +$629K ﹤0.01% 2175
2020
Q2 		$3.5M Buy
+145,799
New +$2.96M ﹤0.01% 2299
2020
Q1 		– Sell
-10,294
Closed -$213K – 3649
2019
Q4 		$213K Buy
+10,294
New +$206K ﹤0.01% 3560

Other funds holding BSTZ

SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return

Ameriprise's BSTZ Position: Q2 2026 in Review

Ameriprise increased its BlackRock Science and Technology Term Trust (BSTZ) stake by 34% in Q2 2026, buying an estimated $264K and bringing the position to 37,720 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #3349.

Ameriprise first reported a position in BSTZ in Q4 2019 and has held it in 26 quarters since. The position peaked at $4.79M in Q1 2021. 152 funds tracked by Wall St. Rank hold BSTZ as of Q2 2026.

  • Ameriprise held 37,720 shares of BlackRock Science and Technology Term Trust worth $1.13M as of Q2 2026.
  • Ameriprise bought 9,552 BlackRock Science and Technology Term Trust shares in Q2 2026, an estimated $264K.
  • BlackRock Science and Technology Term Trust made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3349 holding.
  • Ameriprise first reported a position in BlackRock Science and Technology Term Trust in Q4 2019 and has held it in 26 quarters since.
  • Ameriprise's BlackRock Science and Technology Term Trust position peaked at $4.79M in Q1 2021.
  • 152 funds tracked by Wall St. Rank held BlackRock Science and Technology Term Trust as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.